Page 1 of Clinical Trials for Drug Travoprost 0.004% Travatan, 57 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients
Last Updated: January 14, 2008
Condition(s): Open-Angle Glaucoma
2
Completed
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Last Updated: June 24, 2010
Condition(s): Glaucoma
3
Completed
IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
Last Updated: April 7, 2012
Condition(s): Glaucoma
4
Terminated
Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
Last Updated: February 23, 2010
Condition(s): Intraocular Pressure
5
Completed
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
Last Updated: February 23, 2010
Condition(s): Glaucoma
6
Completed
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
Last Updated: March 12, 2010
Condition(s): Angle-Closure Glaucoma
7
Completed
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
Last Updated: January 12, 2012
Condition(s): Open-angle Glaucoma; Ocular Hypertension
8
Recruiting
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
Last Updated: March 6, 2012
Condition(s): Glaucoma, Open-Angle; Ocular Hypertension
9
Completed
Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
Last Updated: December 4, 2008
Condition(s): Ocular Dryness; Ocular Irritation; Open-Angle Glaucoma; Ocular Hypertension
10
Active, not recruiting
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01%
Last Updated: May 4, 2012
Condition(s): Glaucoma; Intraocular Hypertension
11
Completed
Safety and Efficacy of Travoprost/Timolol BAC-free
Last Updated: April 3, 2012
Condition(s): Open-angle Glaucoma; Ocular Hypertension
12
Completed
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
Last Updated: April 3, 2012
Condition(s): Open-Angle Glaucoma; Ocular Hypertension
13
Completed
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
Last Updated: September 24, 2009
Condition(s): Glaucoma; Ocular Hypertension
14
Completed
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Last Updated: April 5, 2012
Condition(s): Open-angle Glaucoma; Ocular Hypertension
15
Completed
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
Last Updated: March 10, 2010
Condition(s): Glaucoma; Ocular Hypertension
16
Recruiting
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Last Updated: April 19, 2012
Condition(s): Glaucoma
17
Completed
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
Last Updated: April 17, 2012
Condition(s): Glaucoma
18
Completed
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
Last Updated: May 30, 2007
Condition(s): Glaucoma
19
Completed
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
Last Updated: February 7, 2007
Condition(s): Glaucoma
20
Completed
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
Last Updated: August 4, 2008
Condition(s): Glaucoma, Angle-Closure; Ocular Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Travoprost+0.004%25+Travatan

Page 1 of Clinical Trials for Drug Travoprost 0.004% Travatan, 57 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About